A detailed history of Global Retirement Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Global Retirement Partners, LLC holds 391 shares of INCY stock, worth $31,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
391
Previous 395 1.01%
Holding current value
$31,878
Previous $23,000 8.7%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$57.33 - $68.61 $229 - $274
-4 Reduced 1.01%
391 $25,000
Q2 2024

Jul 23, 2024

BUY
$51.18 - $63.75 $4,401 - $5,482
86 Added 27.83%
395 $23,000
Q1 2024

Apr 23, 2024

SELL
$56.55 - $66.59 $622 - $732
-11 Reduced 3.44%
309 $17,000
Q4 2023

Jan 18, 2024

BUY
$52.16 - $64.19 $15,960 - $19,642
306 Added 2185.71%
320 $20,000
Q3 2023

Oct 13, 2023

SELL
$57.77 - $65.93 $173 - $197
-3 Reduced 17.65%
14 $0
Q2 2023

Jul 20, 2023

SELL
$60.95 - $75.51 $731 - $906
-12 Reduced 41.38%
17 $1,000
Q1 2023

May 05, 2023

SELL
$70.23 - $86.01 $6,952 - $8,514
-99 Reduced 77.34%
29 $2,000
Q3 2022

Nov 03, 2022

BUY
$66.18 - $82.86 $794 - $994
12 Added 10.34%
128 $10,000
Q2 2022

Jul 15, 2022

BUY
$66.18 - $83.18 $6,618 - $8,318
100 Added 625.0%
116 $9,000
Q1 2022

Jul 14, 2022

BUY
$66.02 - $79.71 $1,056 - $1,275
16 New
16 $1,000
Q4 2021

Jan 21, 2022

SELL
$63.34 - $74.11 $253 - $296
-4 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$68.67 - $84.02 $68 - $84
1 Added 33.33%
4 $0
Q2 2021

Jul 15, 2021

BUY
$79.87 - $87.53 $239 - $262
3 New
3 $0
Q1 2020

Apr 28, 2020

SELL
$63.18 - $85.97 $379 - $515
-6 Closed
0 $0
Q2 2019

Nov 19, 2019

BUY
$73.52 - $88.7 $441 - $532
6 New
6 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.